Key result
The development of chronic kidney disease in patients with essential hypertension significantly increases cardiovascular risk due to the clustering of metabolic syndrome risk factors.
Why the study?
Does the development of chronic kidney disease in patients with essential hypertension affect cardiovascular prognosis?
Does the development of chronic kidney disease in patients with essential hypertension affect cardiovascular prognosis?
Adequate assessment of renal function is mandatory in hypertensive patients, as mild renal derangement significantly elevates cardiovascular risk.
Renal monitoring remains essential in hypertension; supports consensus on CKD as CV risk multiplier but leaves open prospective validation.
PURPOSE OF REVIEW: This review examines the relevance of the development of chronic kidney disease in long-term hypertensive patients on the cardiovascular prognosis. RECENT FINDINGS: Recently published guidelines recognize the relevance of the development of chronic kidney disease in the stratification of risk for the hypertensive patient. An adequate assessment of renal function, including an estimation of the glomerular filtration rate, is mandatory in order to ensure an adequate evaluation of the global cardiovascular risk in the hypertensive patient. The presence of subtle elevations in serum creatinine concentrations is a potent predictor of a poor cardiovascular prognosis. The clustering of associated risk factors seems to justify the elevated cardiovascular risk observed in patients with essential hypertension and mild renal function derangement. SUMMARY: Chronic kidney disease is associated with a significant increase in cardiovascular risk attributable to the simultaneous existence of other risk factors related to the metabolic syndrome. The high prevalence of chronic kidney disease in the general and hypertensive populations forces the recognition of its relevance and the need for an integrated therapeutic approach simultaneously to protect the renal and cardiovascular systems fully.
No takes yet. Share an insight, caveat, or question.
Segura et al. (2004) conducted a review in Essential hypertension and chronic kidney disease. The development of chronic kidney disease in patients with essential hypertension significantly increases cardiovascular risk due to the clustering of metabolic syndrome risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: